A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)
Clinical trial NCT01614782 · TERMINATED
Trial details
- NCT number
- NCT01614782
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2012-10-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.